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Abstract: When normal lymphatic function is hampered, imperceptible subcutaneous edema can
develop and progress to overt lymphedema. Low-cost reliable devices for objective assessment of
lymphedema are well accepted in clinical practice and research on breast-cancer related lymphedema
but are untested in populations with lymphatic filariasis (LF). This is a cross-sectional analysis of
baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young
people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a
group of antigen-negative controls of similar age and gender were invited to continue in the study.
Tissue compressibility was assessed with three tissue tonometers, and free fluids were assessed
using bio-impedance spectroscopy (BIS). Infection status was confirmed by Og4C3 antigen assay.
At baseline (n = 98), antigen-positive cases had clinically relevant increases in tissue compressibility
at the calf using a digital Indurometer (11.1%, p = 0.021), and in whole-leg free fluid using BIS
(9.2%, p = 0.053). Regression analysis for moderating factors (age, gender, hydration) reinforced the
between-infection group differences. Results demonstrate that sub-clinical changes associated with
infection can be detected in asymptomatic cases. Further exploration of these low-cost devices in
clinical and research settings on filariasis-related lymphedema are warranted.
Keywords: neglected tropical disease; lower extremity; lymphatic filariasis; tissue tonometry;
bio-impedance spectroscopy; lymphedema
1. Introduction
Lymphatic filariasis (LF) is a parasitic disease in which thread-like worms inhabit the human
lymphatic system, where they can impair normal lymphatic pumping. Classified as a neglected
tropical disease and affecting many of the world’s poorest populations, LF can lead to lymphedema,
a progressively debilitating swelling of the skin and subcutaneous tissue in any body part, most
frequently the legs [1]. Normal lymphatic pumping actively removes circulating proteins and fluid
from the tissue spaces, maintaining a slightly negative interstitial pressure. When lymphatic capacity
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is impaired, extracellular fluid (ECF) and circulating proteins begin to accumulate in the interstitial
spaces [2]. If normal lymphatic function is not restored, this initially covert edema gradually becomes
overt, and the affected body part visibly enlarges. Over time, the protein-rich fluid is replaced with
fat and fibrous tissue, and normal limb contours are lost. The outdated eponym ‘elephantiasis’ was
inspired by the appearance of a grossly enlarged limb in late-stage lymphedema where the skin is
thick, discolored, and formed into folds. In developed countries, lymphedema is frequently caused
by surgical damage when lymph nodes are removed or irradiated during cancer treatment. Much
of what is known about initiation and progression of lymphedema comes from research on breast
cancer-related lymphedema (BCRL) of the arm [3].
A wide spectrum of devices and methods is used to objectively evaluate lymphedema depending
on the setting. At the highly resourced end of the spectrum, nuclear imaging and other sophisticated
technologies are often used to assess BCRL of the arm. Tissue tonometry to quantify tissue
compressibility and portable bio-impedance spectroscopy (BIS) to track fluctuations in free fluid
are also used and are relatively inexpensive. Using BIS, it has been shown that covert pathologic
change due to lymphatic damage during breast cancer treatment can be detected, and that early
intervention in this latent stage can prevent the onset of overt disease [4]. At the low-resourced end of
the spectrum, assessment of LF related-lymphedema (LFRL) of the leg usually relies on classification
of visible and palpable soft tissue changes [5], where subjectivity may lead to inconsistent classification.
There is no differentiation or assessment of covert change, so subtle but important alterations in tissue
composition may be missed.
In LF, mosquitoes pick up the microfilariae during a blood meal. The larvae develop to third stage
within the mosquito before being transmitted by a subsequent bite. Transmission is relatively inefficient
with a low risk of infection per bite, and after transmission there is a lag between being infected and the
development of adult worms. This means that most children with LF will remain asymptomatic until
young adulthood, which affords a long, latent period in which to implement preventive strategies [6].
Primary prevention in the Global Program to Eliminate LF (GPELF) is preventive chemotherapy, which
is delivered annually via mass drug administration (MDA) in endemic regions [7]. This will eventually
prevent any new cases of morbidity as infection rates fall too low to sustain transmission. However,
preventive chemotherapy conveys no real benefit to advanced cases, most of whom will no longer
be antigenemic, but will require life-long health care. In between the asymptomatic cases that will
never progress to overt disease and the advanced cases that have irreversible lymphedema, there are
many cases of latent and early stage lymphedema. There is some evidence that MDA may reverse
very early tissue changes in LFRL [8], but without standardized assessment or diagnostic criteria for
Stage 0, or devices sensitive enough to detect small changes in tissue composition, it is not clear at
what stage or which individuals will remain at risk of disease progression. Reliable, sensitive, low-cost
devices to provide objective assessment of LFRL are needed [9].
A pilot study in Papua New Guinea (PNG) found the skin over the posterior thigh was 20% more
compressible in asymptomatic young people who had tested positive for LF antigen compared to
antigen-negative peers, using a mechanical tonometer [10]. Subsequently, three tissue tonometers and
a portable BIS device have demonstrated intra-operator reliability in assessing tissue composition
in the lower limbs of young Australian and Myanmar populations without any history or risk of
lymphedema [11]. It is not yet known if covert lymphedema can be detected by tissue tonometry or
BIS in these populations.
There is no agreed standard for assessment of Stage 0 lymphedema, and diagnostic criteria
for clinical onset are not well defined [3]. One study on BCRL used a 3% change in BIS values to
trigger preventive treatment [4], and clinical lymphologists may use a percentage change in limb
girth or volume to track lymphedema change, with a variation of more than 10% considered clinically
relevant [12]. Variations in body composition will influence measurements with these devices as muscle
holds more free fluid than fat, fat is more compressible than muscle, and the ECF in the subcutaneous
compartment fluctuates slightly depending on overall body hydration. Individual characteristics that
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influence body composition should be considered when assessing superficial tissues of the lower
limb, including expected changes associated with growth from child to young adult and gender-based
differences in muscle and fat distribution. Habitual patterns of muscle use should also be considered,
and significant between-leg differences in healthy young Australian and Myanmar people have been
reported when using these devices [13].
This cross-sectional study on young people residing in an LF endemic region in Central Myanmar
investigated whether tissue tonometry and BIS measures were altered in asymptomatic cases who
tested positive for Wuchereria bancrofti antigen. The results will assist researchers and clinicians to
objectively quantify changes occurring in early LFRL and may contribute to formal recognition and
intervention for Stage 0 lymphedema of the leg.
2. Materials and Methods
2.1. Study Site Selection, Participant Recruitment, and Screening
Sentinel site records kept by the Vector Borne Disease Control (VBDC) Centre in Mandalay
identified Amarapura Township as a densely populated area with a high prevalence of LF. It was
also close enough to laboratory services for blood sample processing. A study site was set up in the
Administration Centre in the village of Nge Toe and baseline data were collected over a two-week
period in October 2014. The study was conducted in accordance with the Declaration of Helsinki and
the protocol was approved by the Myanmar Ministry of Health (MoH) and James Cook University
Human Research Ethics Committee (approval number H5261).
A sample size of 32 in each group was predicted to detect a 10% difference between groups with
80% power, based on a mean mid-calf value of 2.5 with SD of 0.7 using the digital Indurometer [13,14].
A convenience sample of local young people aged 10–21 years was invited to be screened for LF
antigen and to participate in a longitudinal study on early detection of LFRL. Participant information
sheets and informed consent forms were provided in Burmese. Staff of the VBDC and Amarapura
Township Hospital, the World Health Organization (WHO) technical officer for Myanmar (SSW),
and locally-trained research assistants explained all procedures to the participants, determined their
eligibility to participate, and obtained informed consent. Written consent was given by young adults
aged 18–21 and by a parent or guardian for minors aged 10–17. A further verbal assent for each
procedure was obtained from all participants prior to performing that procedure. Participant inclusion
and exclusion criteria are shown in Figure 1.
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2.2. Screening and Baseline Data Collection
A rapid field test for the presence of LF antigen was performed using an immunochromatographic
test (ICT) card (Binax Now, Alere, Waltham, MA, USA). This involved placing a 100 µL draw of blood
from a fingerprick onto a test strip. The sample was allowed to flow for 10 min and the result appeared
as one or two lines across the test strip. One line is a control and if this line was not visible then the test
was voi and if possible, repeated. Appearance of the seco d line indicated the presence of circulating
W. bancrofti antigen that is roduced by adult worms. The young people who tested positive by ICT
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(cases), and a sample of the negative participants of the same age and gender (controls), were invited to
return and participate in the longitudinal study. A James Cook University (JCU) technical staff member
(LB) trained the local research assistants in correct use of the ICT card and selected participants invited
for follow-up.
Participants returned during the following fortnight for the blood draw and device measures.
Local research assistants conducted a short interview to elicit information on current health status,
prescription or traditional medications, surgical history, family history of lymphedema, time since the
last drink (as a proxy for hydration), and if they had consumed preventive chemotherapy during the
previous annual MDA. Leg dominance was determined by asking the question ‘Which foot do you use
to kick a ball?’ Height was measured using a chart marked on a wooden post in centimeters and a set
square, and weight in kilograms was recorded using digital scales purchased locally. Device measures
were conducted in a small side office or screened off area and an adult relative was asked to be present
during the measurement of minors.
2.2.1. Device Measures
Three tissue tonometers were used to assess tissue compressibility. The Indurometer (SA Biomedical
Engineering, Adelaide, Australia) is a hand-held electro-mechanical device with a 1 cm diameter
plunger/indenter extending through a 7 cm diameter reference plate and a built-in force sensor.
The reference plate is aligned to the surface of the skin while the device is pressed evenly into the
tissue. A beep is emitted once the equivalent to 200 g of force has been applied, and the degree of
displacement is displayed in 0.01 increments on a light-emitting diode (LED) screen. An image of
the Indurometer is shown in Figure S1. The mechanical Tonometer (SA Biomedical Engineering,
Adelaide, Australia) is a similar device, in which a 1 cm diameter plunger extends beyond a 7 cm
diameter reference plate. This purely mechanical device uses a 200 g mass to drive the indenter into
the underlying tissue, and the degree of displacement is shown on an analogue scale. Both of these
devices record the displacement of the indenter in relation to the reference plate as an indication of
compliance (compressibility) of the underlying skin and tissue. The values provided by these devices
are not absolute measures and can be considered as arbitrary units used to compare measures of tissue
compressibility [15]. A third device, the SkinFibroMeter (Delfin Technologies, Kuopio, Finland), uses a
smaller reference plate with a 1.25 mm length fixed indenter and built-in force sensors. The reference
plate is pressed evenly onto the skin and the device emits a beep when the equivalent of 50 g has
been applied. The device is applied five times and the average resistance in newtons is displayed on a
digital screen. A tape measure and washable skin marker were used to locate and mark the midpoint
of each thigh (front and back) and the back of each calf, and all tonometry measures were taken at
these marks.
Extracellular and intracellular fluid loads were assessed using bio-impedance spectroscopy (BIS),
which measures the resistance to multifrequency, low-level electrical currents. The difference between
resistance in the intracellular (Ri) and extracellular (Re) fluid compartments was represented as a ratio
Ri:Re. As the intracellular fluid (ICF) compartment is tightly regulated, any changes in the ratio usually
represent changes in the extracellular fluid (ECF). Whole-leg BIS measures were recorded for each leg
with the SFB7 (Impedimed, Australia) using self-adhesive electrodes applied to the skin according to
manufacturer’s instructions for lower limb measures.
A detailed description of data collection methods was published in a reliability study on these
devices in Australia and Myanmar [11]. All devices were operated by the principal researcher (JD),
who was blinded to the infection status of the participants. Tonometry scores were recorded on data
collection sheets by a research assistant, and BIS data was downloaded to an Excel file (Microsoft
Office 365, version 1706).
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2.2.2. Blood Collection and Processing/Storage
Blood samples were collected by local research assistants, who were trained in specific blood
collection and handling protocols by the JCU technician (LB). A 10 mL draw of venous blood was
collected from each participant into cooled ethylenediaminetetraacetic acid (EDTA) anticoagulant
vacutainers (BD Biosciences, North Ryde, Australia). The antigen test was repeated using 100 uL of the
venous blood pipetted onto an ICT card, and the remaining blood was kept on ice until delivery to the
Public Health Laboratory in Mandalay. Separation of plasma and red blood cells was performed using
a centrifuge for 15 min at 3000 rpm; the plasma was transferred into 2-mL cryotubes by pipette in
duplicate (4 mL per person) and stored at−20 ◦C. Once all baseline data had been collected, the plasma
was transferred on dry ice to the Department of Medical Research in Yangon for long-term storage at
−80 ◦C in a monitored freezer connected to a back-up generator and with daily monitoring. There
were no thaws during plasma transportation or storage. One set of the cryotubes was aliquoted
and used to conduct ELISA assay for the presence of Og4C3, an antigen marker for W. bancrofti,
using the recommend 1:4 dilution for plasma as per the manufacturer (Cellabs, Sydney, Australia) kit
instructions [16]. Samples were classified as positive if the antigen units, estimated using the standard
curve of controls provided with the kit, exceeded 32 units. Detailed methods for the ELISA assays
were previously published in a study on diagnostic testing for LF antigen [16].
2.3. Data Analysis
LF antigen-positive cases were defined as those who were positive by either antigen test
(ICT or Og4C3). Body mass index (BMI) was calculated as kg/m2, but adult values cannot be
used for children; therefore, WHO growth charts and definitions were used to identify underweight
participants, who were defined as being more than two standard deviations below the median BMI
for their age [17]. Chi-squared tests, Fisher’s exact tests, and independent samples t-tests were used
to compare antigen-positive and -negative group characteristics at baseline for known moderating
factors. Paired sample t-tests were used to compare device measures of dominant and non-dominant
legs. Statistical analysis was conducted in SPSS version 23 (IBM Corp), and significance was set at
0.05 with a 95% confidence interval. Clinically-relevant difference for tonometry measures was set at
>10% and for BIS measures it was set at >3%. Stepwise regression was performed for dominant and
non-dominant legs separately to determine the level of variance in device measures associated with
infection status (univariate) and other potential moderating factors (multivariate).
3. Results
3.1. Participants
Screening for LF found 60 antigen-positive cases among 316 volunteers, and 114 young people
(57 cases and 57 controls of the same age and gender) were invited to continue in the longitudinal study
(see Figure 2). Ten people either could not be found or refused to return, and 104 participants were
available for baseline blood draw and physical measures. Data from six participants were excluded
from the final analysis; four were found at a later measure to have been outside the target age range
at baseline, one had a prosthetic leg, and another had a heart condition, neither of which had been
disclosed at the screening interview. The final study population was comprised of 46 antigen-positive
cases detected by ICT plus a further four cases identified as antigen positive by Og4C3 ELISA (n = 50).
There were 48 antigen-negative (control) cases.
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3.1.1. Participant Characteristics
All participants (n = 98) were aged between 10 and 21 years (mean 15.3 SD 3.4) and there were
55 females and 43 males. The mean height, weight, and BMI were 152.0 cm (SD 12.0, range 118.8–174.0),
42.3 kg (SD 11.5, range 17.5–82.7), and 18.0 kg/m2 (SD 3.0, range 12.4–29.7), respectively. The cohort
was 95.9% right leg dominant and 13.3% (n = 13) were considered underweight. Almost half (44.9%) of
the participants were working in weaving workshops, 27.6% were students, 8.2% were street vendors,
2.0% were construction workers, and the remaining 17.3% worked in other occupations or did not
disclose their occupation. None had a history of lymphedema in their immediate family, previous
surgery or medical implants, and all were in good health. Two participants were taking prescription
medications and one was using traditional medicine. One participant felt unwell on the day scheduled
for taking the measures and was asked to return when feeling better. Comparing antigen-positive
and antigen-negative groups, there were no significant between-group differences for any physical
attribute or moderating factor. Participant characteristics at baseline are shown in Table 1.
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Table 1. Group characteristics of antigen-positive and antigen-negative participants (positive by either
immunochromatographic test (ICT) or Og4C3) at baseline.
LF Antigen-Positive Cases LF Antigen-Negative Controls
Mean Diff (95% CI) p=
n = 50 n = 48
Age in years—mean (SD) 15.20 (3.38) 15.48 (3.46) 0.28 (−1.09, 1.07) 0.691 a
Gender
Female n (%) 27 (54%) 28 (58%) 0.410 b
Male n (%) 23 (46%) 20 (42%) 0.410 b
Height in cm—mean (SD) 151.80 (12.56) 152.20 (11.52) 0.399 (−4.44, 5.24) 0.870 a
Weight in kg—mean (SD) 42.27 (12.81) 42.30 (10.12) 0.028 (−4.617, 4.670) 0.990 a
BMI in kg/m2—mean (SD) 18.05 (3.46) 18.03 (2.65) −0.012 (−1.239, 1.216) 0.985 a
Body composition n = (%) 0.976 c
Median weight 41 (82%) 40 (83%)
Underweight > −2SD 7 (14%) 6 (13%)
Overweight > +1SD 2 (4%) 2 (4%)
Dominant leg right/left 47/3 47/1 0.324 b
Occupation n = (%) 0.395 c
Student 14 (28%) 13 (27%)
Working/other 32/4 (72%) 34/1 (73%)
Drank liquid n = 97 0.590 c
<60 min 13 (26%) 12 (26%)
>60 min 37 (74%) 35 (74%) (1 NA)
Consumed 2013 MDA n (%) 17 (34%) 22 (46%) 0.383 c
LF = lymphatic filariasis; BMI = body mass index; SD = standard deviation; a independent samples t-test;
b Fishers exact test; c Pearson chi-square; NA = participant was not asked.
3.2. Moderating Factors Associated with Device Measures
3.2.1. Effect of Infection on Device Measures
In the antigen-positive group, tissue compressibility was higher at all measuring points, and
there was more free fluid in both legs compared to that of the antigen negative group. Independent
t-tests found that, at mid-calf on the non-dominant side, the increase in Indurometer measures was
both clinically (11.1%) and statistically significant (p = 0.021). In addition, whole leg BIS measures
found clinically-relevant (>3%) increases in free fluid in both legs (dominant leg, 4.9% (p = 0.220),
non-dominant leg, 9.2% (p = 0.053)). Mean values and between-group differences for the Indurometer
and BIS measures are shown in Table 2. Neither the mechanical Tonometer nor SkinFibroMeter found
any clinically relevant or statistically significant differences between infection groups, with many
differences too small to be evident at two decimal places. The only between-group difference of interest
with these two devices was increased tissue compressibility with the Tonometer at the non-dominant
calf (4.8% softer, p = 0.296). Mean values and between-group differences for all devices including the
Tonometer and SkinFibroMeter are given in Table S1.
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Table 2. Between-infection group differences for Indurometer and BIS measures, size, and direction of variation.
Measurement Point Indurometer
Positive n = 50 Negative n = 48
Mean Difference (%) Direction in Positive Cases p=
Mean (SD) Mean (SD)
Dominant anterior thigh 4.80 (0.76) 4.72 (0.69) 0.05 (1.1%) Softer 0.731
Non-dominant anterior thigh 5.10 (0.88) 5.00 (0.69) 0.10 (1.9%) Softer 0.546
Dominant posterior thigh 4.13 (0.93) 4.06 (0.87) 0.07 (1.7%) Softer 0.701
Non-dominant posterior thigh 3.88 (0.83) 3.86 (0.95) 0.02 (0.4%) Softer 0.933
Dominant calf 2.91 (0.57) 2.70 (0.68) 0.21 (7.8%) Softer 0.096
Non-dominant calf 2.73 (0.65) 2.46 (0.65) 0.27 (11.1%) *,# Softer 0.021
BIS
Dominant leg n = 47/45 2.44 (0.46) 2.56 (0.45) 0.12 (4.9%) # More fluid 0.220
Non-dominant leg n = 46/44 2.62 (0.56) 2.86 (0.59) 0.24 (9.2%) # More fluid 0.053
SD = standard deviation; * Significant between-group difference p ≤ 0.05; # clinically relevant between-group difference.
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3.2.2. Effect of Infection Status, Age, Gender, Body Composition, and Hydration on Device Measures
Regression was first performed with infection status (antigen positivity) alone, and then stepwise
regression was used to add moderating factors. Being antigen positive was significantly associated
with increased compressibility in the non-dominant calf when using the Indurometer (Table 3, step 1)
which is consistent with the t-test results given above in Table 2. Using multivariate regression, after
adjustment for other factors (gender, age, underweight, and hydration), increased compressibility
remained significantly associated with being antigen positive (in the non-dominant calf) using the
Indurometer, and was also significant in the dominant calf using the same device. When considering
all factors, being antigen positive was significantly associated with increased fluid in the non-dominant
leg using BIS (Table 3, step 2).
In the stepwise regression, being female was significantly associated with higher tissue
compressibility using all three tonometers. The largest gender-related effect using the Indurometer was
in calf measures where there is a relatively thin fat layer over the muscles, making small differences in
fat and muscle composition more likely to be detected (dominant leg B (SE) = 0.639 (0.117), p < 0.000)
(see Table 3). The least effect of gender was found over the anterior thighs where the relatively thicker
fat layer reduces the influence of the underlying muscle tone and a small difference between the sexes
is not likely to register as much change. Using BIS, being female was significantly associated with less
free fluid in both legs, and this is consistent with females having relatively smaller muscle/higher
fat mass (less fluid) than males of the same age. The largest coefficient was in the non-dominant leg
(B (SE) = 0.485 (0.103), p < 0.001) (see Table 3).
Being less well hydrated, defined as not having a drink within one hour of measures,
was associated with lower tissue compressibility. This was significant at the non-dominant calf
(B (SE) = −0.239 (0.110), p = 0.032). Being older was significantly associated with a small increase in
free fluid in both legs, consistent with normal growth increase in muscle mass. Being underweight
was significantly associated with a small increase in free fluid in the non-dominant leg (BIS) which
may be associated with reduced fat mass or an increased capillary filtrate due to proteinemia.
In summary, when accounting for known moderating factors of age, gender, BMI, and hydration,
there was a highly significant association between antigen positivity and increased Indurometer
measures at the non-dominant calf (p = 0.007). At the dominant calf, the same association was also
significant (p = 0.038). When these factors are taken into account for BIS measures, there was a
clinically relevant and significant increase in free fluid (Table 2) in the non-dominant leg (p = 0.038).
All associations between moderating factors and device measures are given in Table S2.
Table 3. Stepwise regression for moderating factors associated with variation in Indurometer and
bio-impedance spectroscopy (BIS) measures.
Indurometer BIS
Higher Values = Increased Tissue Compressibility Lower Values = Increased ECF
Posterior Thigh B (SE) Calf B (SE) Whole Leg B (SE)
Factor Dominant Non−dominant Dominant Non−dominant Dominant Non−dominant
Step 1 R2= 0.002 0.000 0.029 0.054 0.017 0.042
Antigen Positive 0.070 (0.182) 0.015 (0.180) 0.212 (0.126) 0.272 (0.116) * −0.117 (0.095) −0.238 (0.122)
Step 2 R2= 0.189 0.187 0.283 0.269 0.283 0.398
Antigen Positive 0.093 (0.168) 0.049 (0.166) 0.234 (0.111) * 0.286 (0.104) ** −0.108 (0.083) −0.210 (0.099) *
Gender = Female 0.751 (0.178) ** 0.679 (0.175) ** 0.639 (0.117) ** 0.492 (0.110) ** 0.230 (0.087) ** 0.485 (0.103) **
Older age 0.022 (0.025) 0.041 (0.025) 0.010 (0.017) 0.024 (0.016) −0.051 (0.012) ** −0.061 (0.015) **
Underweight 0.136 (0.250) 0.277 (0.247) −0.052 (0.165) −0.094 (0.155) −0.237 (0.120) −0.302 (0.142) *
Less Recent Hydration −0.338 (0.177) −0.223 (0.174) −0.139 (0.117) −0.239 (0.110) * 0.107 (0.085) 0.124 (0.101)
ECF = extracellular fluid; SE = standard error; * p < 0.05; ** p < 0.01.
3.3. Patterns of Tissue Compressibility and Free Fluid in Dominant and Non-Dominant Legs
There was a consistent pattern of tissue compressibility at the measurement sites that held
true for all devices and all subgroups by age, gender, or infection status. The most compressible
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tissue was located at the (relatively) fatty anterior thigh, the least compressible tissue was over the
dense tendomuscular junction at mid-calf, and values for the posterior thigh fell between the two.
When comparing dominant and non-dominant legs, a consistent pattern of between-leg differences
was seen and can be attributed to expected muscle activity during a kick. The skin was less
compressible (more muscle tone) over the front of the ‘dominant’ kicking thigh and over the back
of the ‘non-dominant’ thigh and calf muscles that propel the body forward during the kick. Using
BIS, there was more free fluid (more muscle mass or less fat) in the dominant leg compared to the
non-dominant leg (9.6%); this difference was both clinically relevant (>3%) and statistically significant
(p < 0.01) using paired samples t-tests. Mean values and between-leg differences for the Indurometer
and BIS are given in Table 4. Mean values and between-leg differences for all devices including the
Tonometer and SkinFibroMeter and are given in Table S3.
Table 4. Mean values and between-leg differences using the Indurometer and BIS.
Indurometer (n = 98) BIS (n = 90)
Anterior Thigh Posterior Thigh Calf Whole Leg
Dominant leg mean (SD) 4.74 (0.72) 4.10 (0.90) 2.81 (0.63) 2.50 (0.46)
Non−dominant leg mean (SD) 5.05 (0.79) 3.87 (0.89) 2.60 (0.59) 2.74 (0.59)
Mean difference (SD) −0.31 (0.31) 0.23 (0.23) 0.21 (0.21) −0.24 (0.32)
95% CI of the difference −0.41, −0.21 0.11, 0.35 0.13, 0.28 −0.31, −0.17
% difference 6.5% ** 5.6% ** 7.5% ** 9.6% **,#
Direction (dominant leg) Harder Softer Softer More fluid
SD = standard deviation; ** Significant between-leg difference p ≤ 0.01; # Clinically relevant between-leg difference
(tonometry > 10%, BIS > 3%).
The overall pattern of between-leg differences (dominant vs. non-dominant), as demonstrated
by kicking a ball, was maintained in the antigen-positive cases, but the degree of difference was
altered. Figure 3 is a radar graph showing the percentage of between-leg differences in Indurometer
and BIS values for the whole cohort and by infection group. In the infected group, between-thigh
differences in tissue compressibility were exaggerated (closer to the outer ring in the radar chart) but
only slightly, with similar percentage differences for positive (7%), negative (6.1%), and whole cohort
groups (6.5%). The between-infection group differences were more pronounced at the calf where the
mean between-calf difference in the positive cases (6.5%) was much smaller (closer to the middle)
than that of the negative cases (9.7%) or whole cohort (7.5%). Similarly, as well as an overall increase
in free fluid, BIS results indicated that positive cases had smaller between-leg differences compared
to those of their negative counterparts (7.5% vs. 11.7%). Although not statistically significant, these
reduced between-leg differences in the distal legs of the antigen-positive cases suggest a covert edema
overlying and masking normal between-leg variations in muscle tone and mass.
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4. Discussion
In this study, tissue compressibility and free fluid loads were higher in asymptomatic young
people infected with LF compared to their uninfected peers. Both groups displayed normal patterns of
within-leg tissue compressibility; i.e., tissue was most compressible over the anterior thigh and least
compressible at the calf, and between-leg differences were consistent with kicking a ball. However,
when stratified by infection status, the size and direction of between-leg differences in the positive
cases were consistent with a covert accumulation of subcutaneous fluid in the lower leg. Usually,
LFRL appears distally and progresses proximally, so detectable tissue changes may occur earlier at the
calf than at the thigh. The relatively thin layer of skin and tissue over the muscle of the calf may also
render early tissue changes more evident than in fattier parts of the leg. Accordingly, the association
with LF antigenemia and Indurometer measures was statistically significant at mid-calf, and large
enough on the non-dominant side to also be clinically relevant. This early appearance of lymphatic
dysfunction in the non-dominant leg is consistent with reports on BCRL, which show an increased risk
of arm lymphedema if the operated side is also the non-dominant arm [18]. This tendency for fluid
to accumulate more readily on the non-dominant side could be the result of differences in muscular
activity that naturally promotes lymph flow and may be greater or more frequent on the dominant side.
For all devices, the significant associations between higher tissue compressibility and lower free
fluid in females reflect expected variation in muscle to fat ratios between the sexes. Other moderating
factors such as hydration, although not as universal as gender, did have significant associations with
measures at the calf, but this could be reduced by administering a standardized drink during the
assessment protocol. Increased free fluid associated with age and being underweight can be attributed
to a year-by-year increase in muscle mass, or a systemic reduction in fat mass, respectively.
Results in the Myanmar study reinforce earlier findings from PNG [10], where clinically significant
between-infection group differences were found in physical leg measurements. However, some
differences in observations between studies were noted. In particular, in young PNG people, increased
tissue compressibility was found in the posterior thighs of the infected group using the mechanical
Tonometer. In the Myanmar cohort, the between-infection group differences were found using the
digital Indurometer at the calf. There may be several reasons for this discrepancy. The PNG cohort had
a higher proportion of females (64% vs. 54%) than the Myanmar cohort and a higher mean BMI (19.7 vs.
18.05). In addition, age, gender and hydration were not considered in that analysis. In the current study,
the Tonometer did return slightly softer measures in the dominant posterior thigh and non-dominant
calf in the Myanmar group, but in this cohort, the differences were not significant. (Table S1). In PNG,
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no MDA had been available prior to the study, after which treatment was offered to all participants;
in Myanmar, MDA had been offered in 2013 and earlier, although less than half of the participants
reported taking it. Taken together, these two studies provide the first empirical evidence that there are
covert but measurable increases in tissue compressibility and free fluid associated with LF antigenemia,
although the optimal site for assessment may differ for different populations. The advance in the
current study over that done in PNG was the availability of newer, digital devices and inclusion of
age, gender, BMI, and hydration in multivariate regression, which confirmed an independent effect
of infection.
The proportion of all infected individuals that will progress to LFRL, while considered to be
relatively small, is not well understood. It appears to depend on multiple factors including genetics,
geography, exposure to infection, and worm species, and it was not possible in this cross-sectional
study to determine which of the positive cases may be at risk of progression to advanced disease, if any.
The fact that mean between-infection group differences can be objectively measured suggests that there
is an insidious effect of LF antigenemia on skin and subcutaneous tissues in the lower limb, and this
is consistent with the current understanding of the pathogenesis of lymphedema [19,20]. Follow-up
on this Myanmar cohort may provide some insight into individual variation among antigen-positive
persons to define who is most at risk.
The Indurometer gave the clearest indication that tonometry can be used to detect covert lymphatic
change in the lower limb. While the Tonometer and SkinFibroMeter may not have detected latent
changes in asymptomatic cases in this cohort, their use in assessment of established leg lymphedema
from all causes warrants further study. When using these devices to track changes in the same person
over time, moderating factors such as age and gender will be immaterial, hydration can be controlled
for by administering a drink prior to measurement, and any change in BMI can be considered when
interpreting the results, as is already the practice in BCRL. Indurometry and BIS measures may be
useful in monitoring clinical progression in people at risk of lower limb lymphedema and may provide
an inexpensive means to objectively measure lymphedema in LF populations.
The presence and direction of clinically-relevant changes in the antigen-positive cases in Myanmar
support the hypothesis that LF can induce covert changes in the subcutaneous tissues of the lower
limbs. This contributes to the case for formal recognition of a Stage 0 in the classification of LF-related
lymphedema. The disparity in resources between BCRL and LFRL settings should not be a barrier to
transferring reliable and effective protocols for early detection and intervention in lymphedema to
LF populations.
Supplementary Materials: The following are available online at www.mdpi.com/2414-6366/2/4/50/s1,
Figure S1: Indurometer, SA Biomedical Engineering; Table S1: Between-infection group differences (independent
samples t-test) for (a) Digital Indurometer, (b) Mechanical Tonometer, (c) SkinFibroMeter and (d) BIS measures,
size and direction of variation; Table S2: Stepwise regression for moderating factors associated with variation in (a)
Digital Indurometer, (b) Mechanical Tonometer, (c) SkinFibroMeter and (d) BIS measures; Table S3: Mean values
and between-leg differences (paired samples t-test) for (a) Digital Indurometer, (b) Mechanical Tonometer,
(c) SkinFibroMeter and (d) BIS measures.
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